GENMAB A/S
GMAB·372303206·US·ADR·Healthcare - Biotechnology
GMAB (GENMAB A/S) is held by 108 institutional investors as of Q1 2026. Largest holders: Orbis Allan Gray Ltd ($346.8M), ALLIANCEBERNSTEIN L.P. ($294.4M), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ($133.5M). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 60 funds bought GMAB.
108
Holders
(13 Elite)
$1.7B
Total Value
50% (121)
Consensus
60 buying - 61 selling
13F: Insider & Congress:
Who's Trading
Top Holders
Showing 1-20 of 127
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer